Spots Global Cancer Trial Database for alveolar soft part sarcoma

Every month we try and update this database with for alveolar soft part sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors	NCT02867592	Adrenal Cortica... Alveolar Soft P... Central Nervous... Childhood Clear... Clear Cell Sarc... Ewing Sarcoma Hepatoblastoma Hepatocellular ... Osteosarcoma Recurrent Adren... Recurrent Alveo... Recurrent Clear... Recurrent Ewing... Recurrent Hepat... Recurrent Hepat... Recurrent Kidne... Recurrent Malig... Recurrent Osteo... Recurrent Prima... Recurrent Renal... Recurrent Rhabd... Recurrent Soft ... Recurrent Thyro... Refractory Adre... Refractory Alve... Refractory Clea... Refractory Ewin... Refractory Hepa... Refractory Hepa... Refractory Mali... Refractory Oste... Refractory Prim... Refractory Prim... Refractory Rena... Refractory Rhab... Refractory Soft... Refractory Thyr... Refractory Wilm... Renal Cell Carc... Rhabdomyosarcom... Soft Tissue Sar... Solid Neoplasm Thyroid Gland M... Wilms Tumor	Cabozantinib Cabozantinib S-... Pharmacological...	2 Years - 30 Years	National Cancer Institute (NCI)
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)	NCT03016819	Alveolar Soft P... Leiomyosarcoma Synovial Sarcom... Soft-Tissue Sar...	AL3818 Dacarbazine AL3818 or place...	18 Years -	Advenchen Laboratories, LLC
Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma	NCT03880123	Liposarcoma Malignant Perip... Alveolar Soft P... Ewing Sarcoma Sarcoma	Selinexor Ixazomib	14 Years -	Columbia University
Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas	NCT02636725	Alveolar Soft P... Soft Tissue Sar...	Axitinib Pembrolizumab	16 Years -	University of Miami
Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma	NCT00942877	Sarcoma, Alveol...	AZD2171	- 16 Years	National Institutes of Health Clinical Center (CC)
Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma	NCT03880123	Liposarcoma Malignant Perip... Alveolar Soft P... Ewing Sarcoma Sarcoma	Selinexor Ixazomib	14 Years -	Columbia University
Sunitinib or Cediranib for Alveolar Soft Part Sarcoma	NCT01391962	Sarcoma, Alveol...	Cediranib Sunitinib	16 Years - 120 Years	National Institutes of Health Clinical Center (CC)
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery	NCT02180867	Alveolar Soft P... Angiomatoid Fib... Atypical Fibrox... Clear Cell Sarc... Epithelioid Mal... Epithelioid Sar... Extraskeletal M... Extraskeletal O... Fibrohistiocyti... Fibrosarcoma Inflammatory My... Intimal Sarcoma Leiomyosarcoma Liposarcoma Liver Embryonal... Low Grade Fibro... Low Grade Myofi... Malignant Cutan... Malignant Perip... Malignant Trito... Mesenchymal Cho... Myxofibrosarcom... Myxoid Chondros... Myxoinflammator... Nerve Sheath Ne... PEComa Pericytic Neopl... Plexiform Fibro... Sclerosing Epit... Skin Glomus Tum... Stage IB Soft T... Stage IIB Soft ... Stage III Soft ... Stage IV Soft T... Synovial Sarcom... Undifferentiate...	Doxorubicin Doxorubicin Hyd... Ifosfamide Pazopanib Pazopanib Hydro... Radiation Thera... Therapeutic Con...	2 Years -	National Cancer Institute (NCI)
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery	NCT02180867	Alveolar Soft P... Angiomatoid Fib... Atypical Fibrox... Clear Cell Sarc... Epithelioid Mal... Epithelioid Sar... Extraskeletal M... Extraskeletal O... Fibrohistiocyti... Fibrosarcoma Inflammatory My... Intimal Sarcoma Leiomyosarcoma Liposarcoma Liver Embryonal... Low Grade Fibro... Low Grade Myofi... Malignant Cutan... Malignant Perip... Malignant Trito... Mesenchymal Cho... Myxofibrosarcom... Myxoid Chondros... Myxoinflammator... Nerve Sheath Ne... PEComa Pericytic Neopl... Plexiform Fibro... Sclerosing Epit... Skin Glomus Tum... Stage IB Soft T... Stage IIB Soft ... Stage III Soft ... Stage IV Soft T... Synovial Sarcom... Undifferentiate...	Doxorubicin Doxorubicin Hyd... Ifosfamide Pazopanib Pazopanib Hydro... Radiation Thera... Therapeutic Con...	2 Years -	National Cancer Institute (NCI)
Sunitinib or Cediranib for Alveolar Soft Part Sarcoma	NCT01391962	Sarcoma, Alveol...	Cediranib Sunitinib	16 Years - 120 Years	National Institutes of Health Clinical Center (CC)
AB122 Platform Study	NCT04999761	Advanced or Met... Pancreatic Duct... Colorectal Canc... Non-small Cell ... Gastric Cancer Alveolar Soft P...	AB122 AB122 AB122 TAS-116 AB122 TAS-116 AB122 TAS-116 AB122 TAS-120 AB122 TAS-115 AB122 TAS-115 AB122 TAS-102 Ramucirumab AB122 TAS-102 Bevacizumab	18 Years -	Taiho Pharmaceutical Co., Ltd.
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)	NCT03016819	Alveolar Soft P... Leiomyosarcoma Synovial Sarcom... Soft-Tissue Sar...	AL3818 Dacarbazine AL3818 or place...	18 Years -	Advenchen Laboratories, LLC
Pazopanib for Metastatic Alveolar Soft Part Sarcoma	NCT02113826	Metastatic Alve...	Pazopanib	18 Years -	Seoul National University Hospital
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg	NCT04332874	Sarcoma Myxofibrosarcom... Undifferentiate... Alveolar Soft P...	Isolated Limb I... Pembrolizumab infusion of mel...	12 Years -	Memorial Sloan Kettering Cancer Center
Collection of Alveolar Soft Part Sarcoma and Blood Specimens for Research	NCT00340353	Alveolar Soft P... Sarcoma		4 Years -	National Institutes of Health Clinical Center (CC)
AB122 Platform Study	NCT04999761	Advanced or Met... Pancreatic Duct... Colorectal Canc... Non-small Cell ... Gastric Cancer Alveolar Soft P...	AB122 AB122 AB122 TAS-116 AB122 TAS-116 AB122 TAS-116 AB122 TAS-120 AB122 TAS-115 AB122 TAS-115 AB122 TAS-102 Ramucirumab AB122 TAS-102 Bevacizumab	18 Years -	Taiho Pharmaceutical Co., Ltd.
Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas	NCT02636725	Alveolar Soft P... Soft Tissue Sar...	Axitinib Pembrolizumab	16 Years -	University of Miami

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: